Evidence map›Paper›PMID 34229105›Full record

ArticleActa biomaterialia2021

Bioactive in situ crosslinkable polymer-peptide hydrogel for cell delivery to the intervertebral disc in a rat model.

Marcos N Barcellona, Julie E Speer, Liufang Jing, Deepanjali S Patil, Munish C Gupta, Jacob M Buchowski, Lori A Setton

Open access · hybridAbstract read
In one paragraph

Article in Acta biomaterialia, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Advances and Prospects in Biomaterials for Intervertebral Disk Regeneration.Frontiers in bioengineering and biotechnology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Marcos N BarcellonaDepartment of Biomedical Engineering, Washington University in St. Louis, United States.
Julie E SpeerDepartment of Biomedical Engineering, Washington University in St. Louis, United States.
Liufang JingDepartment of Biomedical Engineering, Washington University in St. Louis, United States.
Deepanjali S PatilDepartment of Biomedical Engineering, Washington University in St. Louis, United States.
Munish C GuptaDepartment of Orthopedic Surgery, Washington University School of Medicine, United States.
Jacob M BuchowskiDepartment of Orthopedic Surgery, Washington University School of Medicine, United States.
Lori A SettonDepartment of Biomedical Engineering, Washington University in St. Louis, United States; Department of Orthopedic Surgery, Washington University School of Medicine, United States. Electronic address: setton@wustl.edu.
Washington University in St. Louis · US

Funding

X-RAY RESEARCH AND DEVELOPMENT WITH/WITHOUT LIVE ANIMALSP41RR005959 · NCRR · DUKE UNIVERSITY · PI PANDIT, PRACHI · 1990 to 2011
$16.0M
Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)P30AR074992 · NIAMS · WASHINGTON UNIVERSITY · PI MATTHEW J SILVA · 2019 to 2026
$6.8M
Intervertebral Disc Degeneration and Cross-Talk with the Nervous System - NOSI Diversity SupplementR01AR077678 · NIAMS · WASHINGTON UNIVERSITY · PI SETTON, LORI A., TANG, SIMON YUE-CHEONG · 2020 to 2024
$3.7M
Intra-Articular Delivery of Sustained Release NF-kB Antagonists In ArthritisR01AR070975 · NIAMS · WASHINGTON UNIVERSITY · PI SETTON, LORI A. · 2017 to 2021
$1.7M
Engineering Microenvironments for the Nucleus Pulposus CellR01AR069588 · NIAMS · WASHINGTON UNIVERSITY · PI SETTON, LORI A. · 2016 to 2019
$1.2M
Use of polymer-peptide system to deliver cells for intervertebral disc regenerationR41AR079324 · NIAMS · BIORESTORATIVE THERAPIES, INC. · PI SILVA, FRANCISCO J · 2021 to 2021
$257k
NCRR NIH HHS P41 RR005959NIAMS NIH HHS P30 AR074992NIAMS NIH HHS R01 AR069588NIAMS NIH HHS R01 AR070975NIAMS NIH HHS R01 AR077678NIAMS NIH HHS R41 AR079324
6 · The paper itself

Abstract

Degeneration of the intervertebral disc (IVD) is associated with significant biochemical and morphological changes that include a loss of disc height, decreased water content and decreased cellularity. Cell delivery has been widely explored as a strategy to supplement the nucleus pulposus (NP) region of the degenerated IVD in both pre-clinical and clinical trials, using progenitor or primary cell sources. We previously demonstrated an ability for a polymer-peptide hydrogel, serving as a culture substrate, to promote adult NP cells to undergo a shift from a degenerative fibroblast-like state to a juvenile-like NP phenotype. In the current study, we evaluate the ability for this peptide-functionalized hydrogel to serve as a bioactive system for cell delivery, retention and preservation of a biosynthetic phenotype for primary IVD cells delivered to the rat caudal disc in an anular puncture degeneration model. Our data suggest that encapsulation of adult degenerative human NP cells in a stiff formulation of the hydrogel functionalized with laminin-mimetic peptides IKVAV and AG73 can promote cell viability and increased biosynthetic activity for this population in 3D culture in vitro. Delivery of the peptide-functionalized biomaterial with primary rat cells to the degenerated IVD supported NP cell retention and NP-specific protein expression in vivo, and promoted improved disc height index (DHI) values and endplate organization compared to untreated degenerated controls. The results of this study suggest the physical cues of this peptide-functionalized hydrogel can serve as a supportive carrier for cell delivery to the IVD. STATEMENT OF SIGNIFICANCE: Cell delivery into the degenerative intervertebral disc has been widely explored as a strategy to supplement the nucleus pulposus. The current work seeks to employ a biomaterial functionalized with laminin-mimetic peptides as a cell delivery scaffold in order to improve cell retention rates within the intradiscal space, while providing the delivered cells with biomimetic cues in order to promote phenotypic expression and increase biosynthetic activity. The use of the in situ crosslinkable material integrated with the native IVD, presenting a system with adequate physical properties to support a degenerative disc.

Indexed as

Intervertebral DiscIntervertebral Disc DegenerationNucleus PulposusAnimalsHydrogelsPeptidesPolymersRatsHydrogelsPeptidesPolymers3D cell cultureCell adhesive mimetic peptideIn vivoNucleus pulposus

Identifiers

PMID34229105
PMCPMC9157564
OpenAlexW3178977122

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.